ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer-Reference-Cited by-同舟云学术

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer

Published:2002-02 Issue:1 Volume:29 Page:37-46
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Raben David,Helfrich Barbara A.,Chan Dan,Johnson Gary,Bunn Paul A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference36 articles.

1. Cancer Statistics 2001;Greenlee;CA Cancer J Clin,2001

2. Genetic mechanisms of solid tumor oncogenesis;Kelly;Adv Int Med,1998

3. A comparison of epidermal growth factor receptor levels and other prognostic parameters in non–small cell lung cancer;Fujino;Eur J Cancer,1996

4. Evidence for a role of EGF receptor in the progression of human lung carcinomas;Pavelic;Anticancer Res,1993

5. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous lung carcinomas;Volm;Br J Cancer,1998

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. X-ray-controllable release of carbon monoxide potentiates radiotherapy by ultrastable hybrid nanoreservoirs;Biomaterials;2023-11

2. HER Receptor, Current, and Emerging Therapeutic Targets;Handbook of Cancer and Immunology;2023

3. The treatment in patients with unresectable locally advanced non-small cell lung cancer: Explorations on hot issues;Cancer Letters;2022-12

4. Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinoma;Life Sciences;2021-03

5. EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm, current evidence, and challenges;Tumori Journal;2020-11-05